乙化介导的表观遗传后果对生物控制和癌症的影响
Andrew J Fritz1,2,3, Kyle T McKay2,3,4, Haley W Greenyer1,2,3
1Department of Biochemistry, University of Vermont, Burlington, VT, USA.
Results and problems in cell differentiation
|July 1, 2025
概括
希斯乙化在表观遗传上控制了基因活动. 针对这一过程,通过纠正异常的基因表达和减少副作用,为癌症治疗提供了新的选择.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 希斯乙化在表观遗传上调节基因转录,影响基因激活和抑制.
- 乙化基因素状态对基因促进剂和增强剂活性至关重要,影响调节性蛋白相互作用和染色质组织.
- 激素乙化中的变化与细胞转化和瘤进展有关.
研究的目的:
- 探索素乙化在基因调节和癌症中的作用.
- 调查针对癌症治疗的向激素乙化机制的潜力.
主要方法:
- 对表观遗传机制的审查.
- 分析基因表达中的基因乙化作用.
- 探索向色素乙化的治疗策略.
主要成果:
- 基因组乙化在响应生理信号时动态控制基因转录.
- 乙化组合素状态决定基因促进剂和增强剂的活性,影响染色质结构.
- 向激素乙化机制为癌症治疗提供了一个有前途的途径,提供了特异性和潜在的副作用.
结论:
- 希斯乙化是基因表达的关键表观遗传调节剂.
- 激素乙化失调与癌症的发展有关.
- 向激素乙化通路对于癌症治疗具有治疗潜力.
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Covalently Linked Protein Regulators
7.4K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.4K
Spreading of Chromatin Modifications
8.5K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.5K
Histone Modification
14.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
14.1K
Phase II Reactions: Acetylation Reactions
373
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
373
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K


